Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Anti-Cancer Drugs|March 14, 2007
A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancerKyoichi Kaira, Noriaki Sunaga, Noriko Yanagitani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinomaYoshio Tomizawa, Takashi Kohno, Haruhiko Kondo, et al.Internal Medicine (Tokyo, Japan)|March 3, 2009
Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphomaHisao Imai, Noriaki Sunaga, Kyoichi Kaira, et al.Chemotherapy|July 17, 2020
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung CancerMie Kotake, Tomohito Kuwako, Hisao Imai, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancerShinji Atagi, Masaaki Kawahara, Yoko Kusunoki, et al.European Journal of Cancer (Oxford, England : 1990)|December 17, 2011
A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancerTomoya Kawaguchi, Minoru Takada, Masahiko Ando, et al.Journal of Clinical Biochemistry and Nutrition|June 12, 2008
Five-antituberculosis Drug-resistance Genes Detection Using Array SystemYasuo Shimizu, Kunio Dobashi, Yoko Yoshikawa, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2007
Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapyNoriaki Sunaga, Yoshio Tomizawa, Noriko Yanagitani, et al.Journal of Geriatric Oncology|August 25, 2022
Predicting systemic therapy toxicity in older adult patients with advanced non-small cell lung cancer: A prospective multicenter study of National Hospital Organization in JapanMasaki Kanazu, Mototsugu Shimokawa, Ryusei Saito, et al.Lung Cancer (Amsterdam, Netherlands)|July 28, 2009
Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancerKyoichi Kaira, Noriaki Sunaga, Noriko Yanagitani, et al.Pageof 7